These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11599032)

  • 21. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
    Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
    Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma.
    Qiu SJ; Zhang XL; Zhang Y; Jiang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):241-6. PubMed ID: 17425962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
    Chuang MT; Liu YS; Tsai YS; Chen YC; Wang CK
    PLoS One; 2016; 11(1):e0141438. PubMed ID: 26741961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma.
    Sijens PE; van Dijk P; Oudkerk M
    Magn Reson Med; 1994 Nov; 32(5):549-55. PubMed ID: 7808255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton MR spectroscopy of pediatric cerebellar tumors.
    Wang Z; Sutton LN; Cnaan A; Haselgrove JC; Rorke LB; Zhao H; Bilaniuk LT; Zimmerman RA
    AJNR Am J Neuroradiol; 1995 Oct; 16(9):1821-33. PubMed ID: 8693982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Wald LL; Nelson SJ; Day MR; Noworolski SE; Henry RG; Huhn SL; Chang S; Prados MD; Sneed PK; Larson DA; Wara WM; McDermott M; Dillon WP; Gutin PH; Vigneron DB
    J Neurosurg; 1997 Oct; 87(4):525-34. PubMed ID: 9322843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
    Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
    J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T.
    Tsougos I; Svolos P; Kousi E; Fountas K; Theodorou K; Fezoulidis I; Kapsalaki E
    Cancer Imaging; 2012 Oct; 12(3):423-36. PubMed ID: 23108208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
    Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy.
    Kamada K; Houkin K; Abe H; Sawamura Y; Kashiwaba T
    Neurol Med Chir (Tokyo); 1997 Mar; 37(3):250-6. PubMed ID: 9095625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?
    Hourani R; Brant LJ; Rizk T; Weingart JD; Barker PB; Horská A
    AJNR Am J Neuroradiol; 2008 Feb; 29(2):366-72. PubMed ID: 18055564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors.
    Lin A; Bluml S; Mamelak AN
    J Neurooncol; 1999; 45(1):69-81. PubMed ID: 10728912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of brain tumors using 1H magnetic resonance spectroscopy.
    McBride DQ; Miller BL; Nikas DL; Buchthal S; Chang L; Chiang F; Booth RA
    Surg Neurol; 1995 Aug; 44(2):137-44. PubMed ID: 7502203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton magnetic resonance chemical shift imaging (1H CSI)-directed stereotactic biopsy.
    Son BC; Kim MC; Choi BG; Kim EN; Baik HM; Choe BY; Naruse S; Kang JK
    Acta Neurochir (Wien); 2001; 143(1):45-9; discussion 49-50. PubMed ID: 11345717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
    Fan G; Sun B; Wu Z; Guo Q; Guo Y
    Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.